Biomaterial Database

Business models for biomaterials in regenerative medicine. 2005

David Williams

Clinical Engineering Department, Royal Liverpool University Hospital, Liverpool, UK. dfw@ce@liverpool.ac.uk

The emergence of new therapeutic methods and technologies, including those associated with regenerative medicine, has required new thinking about regulation, reimbursement and business models. Some of the issues that particularly relate to the materials used in these technologies are discussed in this article.

UI	MeSH Term	Description	Entries
D007753	Laboratories	Facilities equipped to carry out investigative procedures.	Laboratory
D012051	Reimbursement Mechanisms	Processes or methods of reimbursement for services rendered or equipment.	Mechanism, Reimbursement,Mechanisms, Reimbursement,Reimbursement Mechanism
D005060	Europe	The continent north of AFRICA, west of ASIA and east of the ATLANTIC OCEAN.	Northern Europe,Southern Europe,Western Europe
D005161	Facility Regulation and Control	Formal voluntary or governmental procedures and standards required of hospitals and health or other facilities to improve operating efficiency, and for the protection of the consumer.	Facility Control,Facility Regulation,Regulation, Facility,Control, Facility,Controls, Facility,Facility Controls,Facility Regulations,Regulations, Facility
D005376	Financial Management	The obtaining and management of funds for institutional needs and responsibility for fiscal affairs.	Endowments,Financial Activities,Funds,Activities, Financial,Activity, Financial,Endowment,Financial Activity,Fund,Management, Financial
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001672	Biocompatible Materials	Synthetic or natural materials, other than DRUGS, that are used to replace or repair any body TISSUES or bodily function.	Biomaterials,Bioartificial Materials,Hemocompatible Materials,Bioartificial Material,Biocompatible Material,Biomaterial,Hemocompatible Material,Material, Bioartificial,Material, Biocompatible,Material, Hemocompatible
D017149	Private Sector	That distinct portion of the institutional, industrial, or economic structure of a country that is controlled or owned by non-governmental, private interests.	Private Enterprise,Enterprise, Private,Enterprises, Private,Private Enterprises,Sector, Private
D048091	Guided Tissue Regeneration	Procedures for enhancing and directing tissue repair and renewal processes, such as BONE REGENERATION; NERVE REGENERATION; etc. They involve surgically implanting growth conducive tracks or conduits (TISSUE SCAFFOLDING) at the damaged site to stimulate and control the location of cell repopulation. The tracks or conduits are made from synthetic and/or natural materials and may include support cells and induction factors for CELL GROWTH PROCESSES; or CELL MIGRATION.	Regeneration, Guided Tissue,Tissue Regeneration, Guided
D023822	Tissue Engineering	Generating tissue in vitro for clinical applications, such as replacing wounded tissues or impaired organs. The use of TISSUE SCAFFOLDING enables the generation of complex multi-layered tissues and tissue structures.	Engineering, Tissue